Why the study?
Does low-dose aspirin prevent stroke and death as effectively as high-dose aspirin in patients with TIAs and stroke?
Does low-dose aspirin prevent stroke and death as effectively as high-dose aspirin in patients with TIAs and stroke?
Answers are grounded in this paper and cite their sources.
The authors challenge the prevailing assumption that low-dose aspirin (≤325 mg/day) is as effective as high-dose aspirin (>975 mg/day) for stroke prevention in patients with TIAs and stroke.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dyken et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: